| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Wen Xian CEO | XSHE Exchange | CNE1000034C5 ISIN |
| CN Country | 1,309 Employees | 9 Jan 2025 Last Dividend | - Last Split | - IPO Date |
Wuhan Hiteck Biological Pharma Co., Ltd is a pioneering biopharmaceutical entity concentrated on the development, manufacturing, and distribution of bioengineering products and freeze-dried powder injections within China. Founded in 1992, the company has established a formidable presence in the biopharmaceutical sector, driven by its commitment to innovation and quality in addressing complex health challenges. Its comprehensive portfolio spans across various therapeutic areas, notably in the nervous system, oncology, and infectious diseases, showcasing its versatility and dedication to advancing healthcare.